Your browser doesn't support javascript.
loading
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
Yarur, Andres J; Abreu, Maria T; Deepak, Parakkal; Beniwal-Patel, Poonam; Papamichael, Konstantinos; Vaughn, Byron; Bruss, Alexandra; Sekhri, Shaina; Moosreiner, Andrea; Gu, Phillip; Kennedy, William; Dubinsky, Marla; Cheifetz, Adam; Melmed, Gil Y.
Afiliación
  • Yarur AJ; Division of Gastroenterology and Hepatology, Center for Inflammatory Bowel Diseases, Cedars Sinai Medical Center, Los Angeles, California, USA.
  • Abreu MT; Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Deepak P; Center for Inflammatory Bowel Diseases, Division of Gastroenterology and Hepatology, University of Miami, Miller School of Medicine, Miami, Florida, USA.
  • Beniwal-Patel P; Division of Gastroenterology and Hepatology, Washington University, St Louis, Missouri, USA.
  • Papamichael K; Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Vaughn B; Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth-IsraelDeaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Bruss A; Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA.
  • Sekhri S; Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Moosreiner A; Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Gu P; Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Kennedy W; Division of Gastroenterology and Hepatology, Center for Inflammatory Bowel Diseases, Cedars Sinai Medical Center, Los Angeles, California, USA.
  • Dubinsky M; Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Cheifetz A; Division of Pediatric Gastroenterology and Nutrition, Mount Sinai Kravis Children's Hospital, Icahn School of Medicine Mount Sinai, New York, USA.
  • Melmed GY; Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth-IsraelDeaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Am J Gastroenterol ; 118(11): 2005-2013, 2023 11 01.
Article en En | MEDLINE | ID: mdl-37207314

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Grasa Intraabdominal Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Am J Gastroenterol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Grasa Intraabdominal Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Am J Gastroenterol Año: 2023 Tipo del documento: Article